Cohance Approves Key Governance Changes and Stock Option Plans in Postal Ballot Vote
The members of Cohance Lifesciences Ltd have approved several critical resolutions related to appointments, executive remuneration, and stock option programs following a postal ballot conducted across the company’s shareholders base. The voting concluded on June 13, 2026, with the results being scrutinized by Mr. DVM Gopal of Mis. DVM & Associates LLP.The five resolutions put before the members were duly passed with requisite majority. These approvals include the appointment and related remuneration of Mr. Umang Vohra (DIN: 02296740), establishment of a new Employee Stock Option Plan, and the grant of stock options tied to issued capital.
Overview of Approved Resolutions
The postal ballot sought approval for the following key matters:1. Appointment of Mr. Umang Vohra (DIN: 02296740) as Chairman of the Company (effective from May 1, 2026) and Group Chief Executive Officer of the Company (effective from May 20, 2026).
2. Payment of remuneration to Mr. Umang Vohra in excess of the limits prescribed under Section 197 of the Companies Act, 2013.
3. The 'Cohance Lifesciences Limited - Employee Stock Option Plan, 2026'.
4. Extension of the 'Cohance Lifesciences Limited - Employee Stock Option Plan, 2026' to the unlisted subsidiary companies of the Company.
5. Grant of stock options equal to or exceeding, within one financial year, 1% of the issued capital of the Company at the time of grant of options.
Shareholder Voting Results
The company recorded a total of 382,567,140 shares on the record date for the postal ballot. The voting results across all five resolutions demonstrated significant shareholder support for the proposed corporate changes.Voting figures, broken down by category and mode of voting, are detailed below:
| Voting Metric | Total Shares Held | Votes Polled | % of Votes Polled |
|---|---|---|---|
| Total | 382,567,140 | 342,087,872 | 89.419% |
Voting Results by Resolution
The voting performance for the five special resolutions highlights varying degrees of support across the categories of Promoter and Promoter Group (P&PG), Public Institutions, and Public-Non Institutions.Resolution 1: Appointment of Mr. Umang Vohra (Chairman/CEO)
The resolution proposing the appointment of Mr. Umang Vohra was overwhelmingly supported by the company’s shareholders.
| Voting Category | Total Shares Held | Votes in Favour | % of Votes Polled in Favour |
|---|---|---|---|
| Promoter and Promoter Group (Total) | 219,930,170 | 219,930,170 | 100.00% |
| Public Institutions (Total) | 101,397,311 | 94,978,916 | 94.953% |
| Total | 321,327,481* | 314,909,086* | 98.56% |
\*Note: Totals provided in the source data tables for aggregated comparison.
Resolution 2: Remuneration of Mr. Umang Vohra
The resolution concerning the payment of remuneration to Mr. Umang Vohra was also passed with a strong majority.
| Voting Category | Total Shares Held | Votes in Favour | % of Votes Polled in Favour |
|---|---|---|---|
| Promoter and Promoter Group (Total) | 219,930,170 | 219,930,170 | 100.00% |
| Public Institutions (Total) | 101,397,311 | 57,180,338 | 59.3898% |
| Total | 321,327,481* | 317,110,566* | 98.56% |
Resolution 3: Employee Stock Option Plan, 2026
Approval for the 'Cohance Lifesciences Limited - Employee Stock Option Plan, 2026' was successful, receiving high support from shareholders.
| Voting Category | Total Shares Held | Votes in Favour | % of Votes Polled in Favour |
|---|---|---|---|
| Promoter and Promoter Group (Total) | 219,930,170 | 219,930,170 | 100.00% |
| Public Institutions (Total) | 101,397,311 | 84,554,201 | 87.8213% |
| Total | 321,327,481* | 304,484,373* | 94.63% |
Resolution 4: Extension of Stock Option Plan to Subsidiaries
The resolution extending the stock option plan to the company's unlisted subsidiary companies also passed with significant approval.
| Voting Category | Total Shares Held | Votes in Favour | % of Votes Polled in Favour |
|---|---|---|---|
| Promoter and Promoter Group (Total) | 219,930,170 | 219,930,170 | 100.00% |
| Public Institutions (Total) | 101,397,311 | 84,791,240 | 88.0675% |
| Total | 321,327,481* | 304,721,470* | 94.85% |
Resolution 5: Grant of Stock Options (1% of Issued Capital)
The proposal to grant stock options equivalent to or exceeding 1% of the issued capital in one financial year was approved by members.
| Voting Category | Total Shares Held | Votes in Favour | % of Votes Polled in Favour |
|---|---|---|---|
| Promoter and Promoter Group (Total) | 219,930,170 | 219,930,170 | 100.00% |
| Public Institutions (Total) | 101,397,311 | 55,806,324 | 57.9627% |
| Total | 321,327,481* | 301,584,656* | 93.97% |
COHANCE Stock Price Movement
Shares of Cohance Lifesciences Limited edged higher on Friday, closing at ₹426.95 after gaining 0.79%. The stock saw intraday trading volatility, ranging between a low of ₹422.7 and a high of ₹434.95, as 350,791 shares were traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.